Kobe, Japan

Kenji Akama


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kenji Akama: Innovator in Analyte Detection and Blood Collection Technologies

Introduction

Kenji Akama is a prominent inventor based in Kobe, Japan. He has made significant contributions to the fields of analyte detection and blood collection technologies. With a total of 8 patents to his name, Akama's work has had a substantial impact on medical diagnostics and patient care.

Latest Patents

One of Akama's latest patents is an analyte detection method. This method involves detecting an analyte in a state where a complex composed of the analyte in a sample, a particle capable of bonding to the analyte, and a trapping substance is formed on a substrate. The detection is based on an index associated with the behavior of the particle. Another notable patent is for a blood collection device, which includes a flow path that utilizes capillary action to collect a large amount of blood. This device features an introduction inlet for the subject's blood, a substrate connected to the inlet, and a cooling body for maintaining the flow path.

Career Highlights

Kenji Akama has been instrumental in advancing technologies that enhance the efficiency and accuracy of medical diagnostics. His innovative approaches have led to the development of devices that improve blood collection methods, making them more effective for healthcare providers.

Collaborations

Throughout his career, Akama has collaborated with notable colleagues, including Nobuyasu Hori and Masaya Okada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kenji Akama's contributions to analyte detection and blood collection technologies exemplify his commitment to improving medical diagnostics. His patents reflect a dedication to innovation that continues to benefit the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…